ASCO 2022 Conference Coverage

Forgot your password?

Select specialty

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Breast
Lung
GI
GU
Skin
GYN
Head & Neck
Leukemia
Lymphoma
Myeloma
MDS and MPN
Sarcoma

Playback speed

June 21, 2022

ASCO 2022 Conference Coverage

C. Rodriguez

ASCO 2022 Conference Coverage

C. Rodriguez

ASCO 2022 Conference Coverage

A. Jakubowiak

ASCO 2022 Conference Coverage

A. Jakubowiak

ASCO 2022 Conference Coverage

A. Jakubowiak

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

A. Suvannasankha

Thomas Martin

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

ASCO 2022 Conference Coverage

C. Cerchione

ASCO 2022 Conference Coverage

C. Cerchione

Login

Login

Join VuMedi

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Safety and Clinical Activity of Belantamab Mafodotin With Pembrolizumab in Pts With R/R MM: DREAMM-4 Study

CDK4/6 Inhibitors as First-Line Treatment for HR+, HER2- MBC

Progression on First-Line Therapy in HR+, HER2- MBC: Treatments and …

Lecture Summary - ASCO 2022 on a Post Hoc Analysis of Sustained MRD …

ASCO 2022 on a Post Hoc Analysis of Sustained MRD Negativity From th…

ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell Redirecting Immunot…

Lecture Summary - ASCO 2022 on Elranatamab, a BCMA-Targeted T-Cell R…

ASCO 2022 on the Changing Landscape in Post-Transplant Treatment of …

Lecture Summary - ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR …

ASCO 2022 Subgroup Analysis of the Phase 3 CASTOR and POLLUX Studies…

ASCO 2022 on Myeloma Developing Regimens Using Genomics (MyDRUG) Tri…

Lecture Summary - ASCO 2022 on Myeloma Developing Regimens Using Gen…

Lecture Summary - ASCO 2022 Safety and Clinical Activity of Belantam…

Health-Related Quality of Life in R/R MM Treated With Teclistamab, a…

ASCO 2022 Comparative Effectiveness of Teclistamab vs. Real-World Tr…

Lecture Summary - ASCO 2022 Comparative Effectiveness of Teclistamab…

Lecture Summary - ASCO 2022 Health-Related Quality of Life in R/R MM…

Lecture Summary - ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL …

ASCO 2022 Birtamimab in Pts With Mayo Stage IV AL Amyloidosis: Ratio…

Lecture Summary - ASCO 2022 on B-PRISM: A Phase II Trial of Combinat…

ASCO 2022 on B-PRISM: A Phase II Trial of Combination of Daratumumab…

Lecture Summary - ASCO 2022 on the Addition of Carfilzomib as a Thir…

ASCO 2022 on the Addition of Carfilzomib as a Third Agent in Lenalid…